2 'outstanding' small-cap ASX shares that could explode: expert

Ask A Fund Manager: Alto Capital's Tony Locantro reveals a pair of small caps that he reckons have a bright future.

| More on:
A group of three scientists talking excitedly while working in a lab on a diabetes test developed by Proteomics International Laboratories which is an ASX share tipped to explode by Alto Capital

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Ask A Fund Manager

The Motley Fool chats with the best in the industry so that you can get an insight into how the professionals think. In this edition, Alto Capital investment advisor Tony Locantro discusses two ASX shares that are ready to break out.

Hottest ASX shares

The Motley Fool: What are the two best stock buys right now?

Tony Locantro: Proteomics International Laboratories Ltd (ASX: PIQ), they're in the mid-eighties [cents]. They have developed the PromarkerD test which can pick up a diabetic kidney disease before it happens, well in advance. The science is proven. 

They just need to roll that out, [and] look at reimbursements. They've been able to manufacture 50,000 components to get that test out. 

They've announced some licensing of an esophageal cancer test as well. They're working on that. And recently, they came out with some positive biomarkers for endometriosis, which affects one in nine women, and this could lead to the world's first non-invasive test because it does take years to diagnose.

The company has some laboratory services which it provides, and the revenue matches the cash burn but you think that their expenditure will increase. The market cap is undemanding at around $85 million. Solid management that owns a lot of the company and I think it has outstanding growth. 

It's an outstanding growth opportunity in the biotech sector. 

The second stock I'm buying is a company called Maronan Metals Limited (ASX: MMA). I should disclose that I was heavily involved in the initial public offering (IPO) at 20 cents. The stock is now trading at 34 cents.

So, they're about to drill at the Maronan lead, silver and copper gold resource in the Cloncurry region of North Queensland. It is already a sizable resource that requires deeper drilling to expand on the 30 million tonnes at 6.5% lead. That includes a hundred million ounces of silver. They also have a separate copper gold resource that's around 11 million tonnes for 300,000 ounces of gold and some copper.

It's in that vicinity of other major mines, and it could be part of a consolidation play in North Queensland. And the company's capped around $50 million and has recently raised $15 million in its IPO. 

Again, we have extensive holdings, but it's one of these companies that has an existing resource. The grades do get better with depth, so they're trying to basically drill and increase the resource. There was a mining study completed in 2016, which showed favourable mining optics. 

So, highly speculative, but those are my two best buys on the market at the moment.

MF: With these minerals companies, are you ever worried about the cyclical nature of commodity prices?

TL: No.

MF: Because they're mainly exploratory companies that you're looking at?

TL: Yeah. 

At the moment, a lot of these mining companies are being hit with COVID issues. They've been hit with cost blowouts. A lot of the gold producers are now having to add dollars to their all-in sustaining cost. 

But my theory is that a good resource will override any commodity price or cycle. And even though they're higher risk, you're still in that exploration phase where you've got to move through DFS [definitive feasibility studies] really to get towards production.

So a big resource, I think it's going to be valued, and it should be noted that around 80% of the mines in Australia are discoveries made around 1980 or [before] that, so there hasn't been a lot of major discoveries and those that are made are rewarded with good re-ratings.

Motley Fool contributor Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Ask a Fund Manager

A businessman wearing a dark suit points at the camera in a gesture to represent Soul Patts encouraging AGL to give more thought to the Brookfield Consortium's takeover bid
Investing Strategies

This ASX share's halved in 5 years, but I'm still sticking with it

Ask A Fund Manager: Chester Asset Management's Rob Tucker picks the stock he'd put away in the bottom drawer for…

Read more »

Three people walk in a line with their heads obscured by dark clouds.
Investing Strategies

Bargain or value trap? Fundie rates 3 ASX 200 shares going for cheap

Ask A Fund Manager: Chester Asset Management's Rob Tucker offers his thoughts on what to do with these troubled stocks.

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Ask a Fund Manager

Fundie loves these 2 ASX 200 shares that are 'difficult to replicate'

Ask A Fund Manager: Chester Asset Management's Rob Tucker names a pair of stocks that are the best buys right…

Read more »

A headshot of Rob Tucker with a cityscape of high rise buildings in the background..
Investing Strategies

How we beat the stock market by 7% per year: fund manager

Ask A Fund Manager: Chester Asset Management's Rob Tucker reveals the secret sauce to running his successful portfolio.

Read more »

Three boxers, two men and a woman, stand in their training wear with fists raised in a fighting stance with serious looks on their faces against a background of a boxing gym.
Ask a Fund Manager

Here's one hot, one lukewarm and one cold ASX share: fundie

Ask A Fund Manager: Capital H Management's Harley Grosser decides whether he would buy three stocks that have plunged in…

Read more »

Capital H Management founder and chief executive Harley Grosser
Small Cap Shares

This $70 million ASX company just pulled off a $40 million deal: fundie

Ask A Fund Manager: Capital H Management's Harley Grosser reveals a pair of small-cap shares ready to take a massive…

Read more »

a climber scales a sheer rock cliff face reaching out for a handhold with foreboding grey clouds gathering in the sky above him.
Investing Strategies

The one ASX share we're holding onto for dear life: experts

Ask A Fund Manager: Discovery Fund's Chris Bainbridge and Mark Devcich also explain why PE ratios are absolute rubbish for…

Read more »

Three people run in a race through deep mud and puddles of water.
Broker Notes

These 3 ASX shares just halved. I would buy one of them: experts

Ask A Fund Manager: Discovery Fund's Chris Bainbridge and Mark Devcich examine whether this trio of stocks are bargain buys…

Read more »